Salvador Fernando, Treviño Begoña, Sulleiro Elena, Bosch-Nicolau Pau, Aznar Ma Luisa, Goterris Lidia, Espinosa-Pereiro Juan, Pou Diana, Sánchez-Montalvá Adrián, Oliveira Inés, Martínez-Campreciós Joan, Serre-Delcor Núria, Sao-Avilés Augusto, Molina Israel
International Health Unit Vall d'Hebron-Drassanes, Infectious Diseases Department, Vall d'Hebron University Hospital, PROSICS Barcelona, Barcelona, Spain; Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain.
International Health Unit Vall d'Hebron-Drassanes, Infectious Diseases Department, Vall d'Hebron University Hospital, PROSICS Barcelona, Barcelona, Spain; Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain.
Travel Med Infect Dis. 2024 Mar-Apr;58:102690. doi: 10.1016/j.tmaid.2024.102690. Epub 2024 Jan 20.
Imported strongyloidiasis in non-endemic countries has increasingly been diagnosed. The aim of the present study is to describe the main epidemiological and clinical characteristics of patients with imported strongyloidiasis attended in a referral International Health Unit and to detect trend changes over a 12-year period.
This is an observational retrospective study including all imported strongyloidiasis cases seen at the International Health Unit Vall d'Hebron-Drassanes (Barcelona, Spain) from January 2009 to December 2020. Epidemiological and clinical characteristics from included patients were collected.
Overall, 865 cases of imported strongyloidiasis were diagnosed, of whom 472 (54.6 %) were men and mean age was 38.7 (SD 13.4) years. Most cases were diagnosed in migrants (830, 96 %). The distribution of the geographic origin was: Latin America (561, 67.6 %), Sub-Saharan Africa (148, 17.8 %), Asia (113, 13.6 %), North Africa (5, 0.6 %), Eastern Europe (2, 0.2 %), and North America (1, 0.1 %). The main reasons for consultation at the Unit were screening of health status (371, 42.9 %), laboratory test alteration (367, 42.4 %), gastrointestinal symptoms (56, 6.5 %), cutaneous symptoms (26, 3 %), and other clinical symptoms (45, 5.2 %). An increase in the number of cases was observed in the last years of the study period.
Imported strongyloidiasis has increasingly been diagnosed in our referral unit, mostly due to screening strategies implementation. Most of the patients were young migrants coming from Latin America, with no symptoms at the time of diagnosis. The optimization of screening strategies will increase the detection and treatment of cases, reducing potential complications.
非流行国家的输入性类圆线虫病诊断病例日益增多。本研究旨在描述在一家国际健康转诊单位就诊的输入性类圆线虫病患者的主要流行病学和临床特征,并检测12年间的趋势变化。
这是一项观察性回顾性研究,纳入了2009年1月至2020年12月在巴塞罗那瓦尔德希伯伦港国际健康单位就诊的所有输入性类圆线虫病病例。收集了纳入患者的流行病学和临床特征。
总体而言,共诊断出865例输入性类圆线虫病病例,其中472例(54.6%)为男性,平均年龄为38.7岁(标准差13.4)。大多数病例在移民中诊断出(830例,96%)。地理来源分布为:拉丁美洲(561例,67.6%)、撒哈拉以南非洲(148例,17.8%)、亚洲(113例,13.6%)、北非(5例,0.6%)、东欧(2例,0.2%)和北美(1例,0.1%)。在该单位就诊的主要原因是健康状况筛查(371例,42.9%)、实验室检查异常(367例,42.4%)、胃肠道症状(56例,6.5%)、皮肤症状(26例,3%)和其他临床症状(45例,5.2%)。在研究期的最后几年观察到病例数有所增加。
在我们的转诊单位,输入性类圆线虫病的诊断日益增多,主要是由于实施了筛查策略。大多数患者是来自拉丁美洲的年轻移民,诊断时无症状。优化筛查策略将增加病例的检测和治疗,减少潜在并发症。